Peripheral T Cell Lymphoma (2)

Active, not recruiting (1)

Recruiting (1)

phase 1 (1)

Innate Pharma (1)

Washington University School of Medicine (1)

Invivoscribe, Inc. (1)

National Cancer Institute (NCI) (1)

T-Cell Leukemia Lymphoma Foundation (1)

lacutamab (1)

lymphotrack tcr clonality assay (1)

peripheral blood draw (1)

tumor biopsy (1)

biological (1)

procedure (1)

Industry (1)

Other (1)

Interventional (1)

Observational (1)

peripheral t cell lymphoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Dec 19, 2022

Recruiting

Apr 4, 2022